Mordon S, Devoisselle J M, Soulie-Begu S, Desmettre T
Pavillon Vancostenobel, Lille University Hospital, Lille Cedex, 59037, France.
Microvasc Res. 1998 Mar;55(2):146-52. doi: 10.1006/mvre.1998.2068.
This study reinvestigates the spectral properties of ICG (Indocyanine green) in vivo, the role of quenching, and the possibility of an interaction of ICG with blood components and/or vessel walls. ICG quenching as a function of concentration was studied by spectrophotometry on whole blood samples from golden hamsters. Fluorescence ICG characteristics were evaluated by front-face fluorometry. In vivo, fluorescence measurements were performed on the femoral artery of golden hamsters. In vitro, on whole blood samples, fluorescence intensity is modified by ICG quenching as concentration increases above 80 microgram/ml. The maximum fluorescence peak is not affected and remains centered at 832 nm. The in vivo measurements display a similar fluorescence intensity shape, which is affected only by ICG concentrations. However, the maximum fluorescence emission peak is modified significantly with time. Between 0 and 120 min, four phases can be distinguished in which a wavelength shift from 826 to 835 nm is observed. The wavelength shift with change in fluorescence intensity observed in vivo could be due to a localization of ICG molecules in sites more hydrophobic than serum proteins. It is possible to hypothesize the presence of an endothelium-bound form with a specific fluorescence spectrum. The amphiphilic properties of ICG are consistent with fixation of some ICG molecules on sites other than plasmatic proteins after injection. The process of fixation of ICG molecules on surface components or within the vascular endothelium could be due to a change in the microenvironment of some ICG molecules.
本研究重新探讨了吲哚菁绿(ICG)在体内的光谱特性、猝灭作用以及ICG与血液成分和/或血管壁相互作用的可能性。通过分光光度法对金黄仓鼠的全血样本研究了作为浓度函数的ICG猝灭。通过前表面荧光法评估ICG的荧光特性。在体内,对金黄仓鼠的股动脉进行荧光测量。在体外,在全血样本上,当浓度增加到80微克/毫升以上时,荧光强度会因ICG猝灭而改变。最大荧光峰不受影响,仍集中在832纳米处。体内测量显示出类似的荧光强度形状,仅受ICG浓度影响。然而,最大荧光发射峰随时间有显著变化。在0至120分钟之间,可以区分出四个阶段,其中观察到波长从826纳米移至835纳米。体内观察到的荧光强度变化伴随的波长 shift 可能是由于ICG分子定位于比血清蛋白更疏水的位点。有可能推测存在具有特定荧光光谱的内皮结合形式。ICG的两亲性质与注射后一些ICG分子固定在血浆蛋白以外的位点一致。ICG分子固定在表面成分或血管内皮内的过程可能是由于一些ICG分子微环境的变化。